Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.

A new Stanford Medicine study reveals that colorblind men face 52% higher bladder cancer death risk because they can't see ...

By Dr. Sanchari Sinha Dutta, Ph.D. A large electronic health record study suggests that difficulty recognizing painless blood ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

The earliest symptoms of bladder cancer may go unnoticed by patients with colorblindness or similar color vision deficiencies ...

Age, smoking, and exposure to toxins are just some of the factors that increase your risk of dying from bladder cancer. But many of the known risks are preventable. Bladder cancer is the sixth most ...

Bladder cancer treatments include surgery, radiation, chemotherapy, immunotherapy, and targeted therapy; the specific approach depends on the cancer’s stage and grade, as well as your overall health ...

The latest data point to improvements for many cancer types and a continued decline in overall cancer mortality.